GR3026584T3 - Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration. - Google Patents

Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration.

Info

Publication number
GR3026584T3
GR3026584T3 GR980400773T GR980400773T GR3026584T3 GR 3026584 T3 GR3026584 T3 GR 3026584T3 GR 980400773 T GR980400773 T GR 980400773T GR 980400773 T GR980400773 T GR 980400773T GR 3026584 T3 GR3026584 T3 GR 3026584T3
Authority
GR
Greece
Prior art keywords
pct
rectal administration
alkylsulphonamides
agonists
pharmaceutical compositions
Prior art date
Application number
GR980400773T
Other languages
English (en)
Inventor
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Original Assignee
Glaxo Lab Sa
Glaxo Wellcome Lab
Glaxo Wellcome Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa, Glaxo Wellcome Lab, Glaxo Wellcome Lab Sa filed Critical Glaxo Lab Sa
Publication of GR3026584T3 publication Critical patent/GR3026584T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
GR980400773T 1992-05-07 1998-04-10 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration. GR3026584T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions
PCT/EP1993/001077 WO1993021916A1 (en) 1992-05-07 1993-05-03 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration

Publications (1)

Publication Number Publication Date
GR3026584T3 true GR3026584T3 (en) 1998-07-31

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980400773T GR3026584T3 (en) 1992-05-07 1998-04-10 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration.

Country Status (33)

Country Link
US (1) US5705506A (el)
EP (1) EP0639072B1 (el)
JP (1) JPH07506570A (el)
KR (1) KR100253111B1 (el)
AT (1) ATE163850T1 (el)
AU (1) AU670083B2 (el)
BE (1) BE1007024A5 (el)
BG (1) BG62120B1 (el)
BR (1) BR1100108A (el)
CA (1) CA2135179C (el)
CH (1) CH685920A5 (el)
CY (1) CY2039B1 (el)
CZ (1) CZ283512B6 (el)
DE (1) DE69317418T2 (el)
ES (1) ES2113533T3 (el)
FR (1) FR2690847B1 (el)
GB (2) GB9209882D0 (el)
GR (1) GR3026584T3 (el)
HK (1) HK95697A (el)
HU (2) HU227338B1 (el)
IE (1) IE75203B1 (el)
IL (1) IL105468A (el)
IT (1) IT1261471B (el)
NO (1) NO306700B1 (el)
NZ (1) NZ252132A (el)
OA (1) OA10109A (el)
RO (1) RO112993B1 (el)
RU (1) RU2118527C1 (el)
SG (1) SG46649A1 (el)
TW (1) TW231970B (el)
UA (1) UA37206C2 (el)
WO (1) WO1993021916A1 (el)
ZA (1) ZA933178B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
ES2367294T3 (es) * 1998-03-26 2011-11-02 Astellas Pharma Inc. Preparación de liberación sostenida de un compuesto macrólido como tacrolimus.
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
PL2124556T3 (pl) 2006-10-09 2015-02-27 Charleston Laboratories Inc Kompozycje farmaceutyczne
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
WO2011006012A1 (en) 2009-07-08 2011-01-13 Charleston Laboratories Inc. Pharmaceutical compositions
KR101825972B1 (ko) 2010-10-15 2018-02-06 콘테라 파르마 에이피에스 운동 장애 치료를 위한 세로토닌 수용체 작용제의 조합
US10561618B2 (en) 2012-04-18 2020-02-18 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
JP2019507181A (ja) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
KR102443161B1 (ko) 2016-07-11 2022-09-14 콘테라 파르마 에이/에스 아침 운동 불능을 치료하기 위한 박동성 약물 전달 시스템

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1171450B (it) * 1980-08-12 1987-06-10 Glaxo Group Ltd Composti eterociclici indolici, procedimento per produrli e composizioni farmaceutiche che li contengono
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
GR79215B (el) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
FR2574077A1 (fr) * 1984-12-04 1986-06-06 Glaxo Group Ltd Derives d'indoles, leur preparation et les compositions pharmaceutiques les contenant
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
PT88255B (pt) * 1987-08-13 1995-03-01 Glaxo Group Ltd Processo para a preparacao de derivados do indole
PT97888B (pt) * 1990-06-07 1998-12-31 Zeneca Ltd Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
US5705506A (en) 1998-01-06
BG62120B1 (bg) 1999-03-31
BE1007024A5 (fr) 1995-02-21
NZ252132A (en) 1996-09-25
IE75203B1 (en) 1997-08-27
NO306700B1 (no) 1999-12-13
GB2266665A (en) 1993-11-10
FR2690847B1 (fr) 1995-06-09
RO112993B1 (ro) 1998-03-30
ITRM930286A1 (it) 1994-11-06
IT1261471B (it) 1996-05-23
CZ283512B6 (cs) 1998-04-15
NO944214L (no) 1994-11-07
DE69317418D1 (de) 1998-04-16
CY2039B1 (en) 1998-04-30
HUT71418A (en) 1995-11-28
AU670083B2 (en) 1996-07-04
OA10109A (en) 1996-12-18
HU227338B1 (en) 2011-04-28
CA2135179A1 (en) 1993-11-11
BG99167A (bg) 1995-06-30
EP0639072A1 (en) 1995-02-22
SG46649A1 (en) 1998-02-20
FR2690847A1 (fr) 1993-11-12
HU211638A9 (en) 1995-12-28
TW231970B (el) 1994-10-11
GB9209882D0 (en) 1992-06-24
RU2118527C1 (ru) 1998-09-10
JPH07506570A (ja) 1995-07-20
EP0639072B1 (en) 1998-03-11
BR1100108A (pt) 1999-12-07
ATE163850T1 (de) 1998-03-15
IE930339A1 (en) 1993-11-17
CA2135179C (en) 2000-12-05
ITRM930286A0 (it) 1993-05-06
WO1993021916A1 (en) 1993-11-11
ES2113533T3 (es) 1998-05-01
CH685920A5 (fr) 1995-11-15
IL105468A0 (en) 1993-08-18
CZ272394A3 (en) 1995-10-18
NO944214D0 (no) 1994-11-04
DE69317418T2 (de) 1998-07-30
UA37206C2 (uk) 2001-05-15
ZA933178B (en) 1994-01-10
GB2266665B (en) 1996-05-22
HK95697A (en) 1997-08-08
AU4064093A (en) 1993-11-29
KR100253111B1 (en) 2000-07-01
IL105468A (en) 1998-09-24
GB9309209D0 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
MY136249A (en) Phenylethanolamine compounds as anti-obesity agents
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
EP0903349A3 (en) CCR-3 receptor antagonists
AP2001002129A0 (en) 5HT1 receptor agonists and metoclopramide for the treatment of migrane.
ATE331726T1 (de) Adenine-derivate
UA27776C2 (uk) Похідні хінуклідину та їх фармацевтично прийнятні солі, що є антагоністами речовини р у ссавців, фармацевтична композиція, що має антагоністичну дію на речовину р у ссавців
DK333884D0 (da) Faste farmaceutiske formuleringer til langsom nulte-ordens frigivelse via kontrolleret overfladeerosion
BG106142A (en) Glucocorticoid receptor modulators
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
KR100253111B1 (en) Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration
IL114600A (en) Thiazole and thiadiazole compounds their preparation and pharmaceutical compositions containing them
IL114598A0 (en) Triazole compounds their preparation and pharmaceutical compositions containing them
BG104008A (en) Insulin resistance tretment with growth hormone secretagogues
EP0485431A4 (en) Partial agonists of the strychnine insensitive glycine modulatory site of the n-methyl-d-aspartate receptor complex as neuropsychopharmacological agents
GR3022615T3 (en) Pharmaceutical compositions based on ebastime or analogues thereof.
UA27108A1 (uk) Аhтрацикліhові глікозиди та їх фармацевтичhо прийhятhі кислотhо-адитивhі солі, спосіб їх одержаhhя, похідhі 1,6-дийод-3-оксапеhтаhу та спосіб їх одержаhhя
AU7681198A (en) Novel compounds
BG102229A (en) Endothelium receptor antagonists
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
FI950209A0 (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
EP1051994A3 (en) 5HT1 receptor agonists and a COX-2 inhibitor for the treatment of migraine